The investigators aimed to investigate the clinical and epidemiological characteristics of neonates who will be born to Covid-19 positive mothers in Turkey. It is a multicentric prospective cohort study designed and destined only in Turkey. The investigators are planning to admit more than 20 Neonatal Intensive Care Units into the survey; nevertheless, the total number may change according to the prevalence of Covid-19 in neonates. The investigators will also inquire into vertical transmission by collecting cord blood, placental, and postnatal serum samples to test for Covid-19 PCR and Covid-19 Ig M and IgG values from the neonates.
The patients will be recruited by a secure database of "Trials Network" with individualized accounts. Plexus Corporation will hold data monitoring and primary analysis.
Study Type
OBSERVATIONAL
Enrollment
90
Recep Tayyip Erdogan University Medical School
Rize, Turkey (Türkiye)
RECRUITINGVertical Transmission
Vertical transmission will be investigated by obtaining neonatal PCR samples in blood, stool and mother milk as well as Neonatal Covid-19 Ig M and Ig G values
Time frame: First 28 days of life
Hospital stay
Hospital span time of the neonates in NICU
Time frame: First 28 days of life
Early neonatal sepsis rate
Early neonatal sepsis rate
Time frame: First 3 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.